Global Animal Parasiticides Market Overview

Global Animal Parasiticides Market Size Was Valued at USD 8.11 Billion In 2022 And Is Projected to Reach USD 12.17 Billion By 2030, Growing at A CAGR of 5.2% From 2023 To 2030.

Animal parasiticides are referred to as antiparasitics, which are utilized for killing parasites infesting pets and livestock mainly. Parasiticidal products are produced by active ingredients with particular efficacies against specific parasites. These active ingredients are comprised of other inert or non-active ingredients to form a parasiticidal formation. The inert ingredients in the formulation are typically solvents such as alcohols & water, preservatives, stabilizers, and implants among others. The term `antiparasitic` suggested the active ingredient in the finished product or the finished product itself. Ectoparasiticides are utilized for removing external parasites such as mites, ticks, lice, flies, and fleas among others while endoparasiticides control internal parasites, including flukes, tapeworms, and roundworms. In addition, some of the endoparasiticides work effectively against parasitic worms, assuming that they are anthelmintics. There is another type of antiparasitic apart from these two, known as the endectocides, which control both internal and external parasites. Moreover, in different economies globally, most of the endoparasiticides are veterinary medicines and ectoparasiticides are pesticides. This is owing to the active ingredients in most of the ectoparasiticides are also deployed as pesticides in the agricultural sector. Chemical structures of most of the active ingredients in all these animal parasiticides are highly alike sharing different features due to which, they can be easily classified into specific families or chemical classes. For instance, there are many chemicals' classes among veterinary parasiticides. These include synthetic pyrethroids, organophosphates, and benzimidazoles, etc. 

COVID-19 Impact on Animal Parasiticides Market

COVID-19 is a rare global public health emergency that has influenced almost every industry, and the long-term effects are estimated to impact the industry growth during the forecast period. While human-to-human transmission of the COVID-19 virus is confirmed, there is restricted evidence regarding the virus infecting animals. There is a possibility for domestic animals to be contaminated by the virus through close contact with infected humans. This is expected to have significant consequences for animal care and welfare. Studies are underway to better understand the inclination of different animal species to the COVID-19. While there is no concrete corroboration, patients are advised to avoid any kind of contact with animals as a precaution. Concerning production, major key players have ensured that their supply chains are not interrupted. Zoetis, Inc., for example, has reported no direct impact on its supply of anti-parasitic drugs. The company is closely observing the situation and has taken several proactive steps. For instance, the company has 4-6 months of strong inventory of key products. Similarly, the company is also securing the successful movement of goods throughout its network. The company has also been boosting its inventory by rising inventory positions for all aspects of its supply chain: finished goods, active ingredients, and supporting components. Furthermore, in April 2020, Merck & Co. declared that it had declined revenue expectations for 2020 by about USD 2.5 billion in anticipation of the poor impact on its animal health segment. Declined veterinary pharmaceutical production capacity and output will lead to product unavailability and hindered supply chains, poorly impacting Animal Parasiticides' market growth throughout 2020–2021.

Market Dynamics And Factors For The Animal Parasiticides Market

Drivers:

The animal parasiticides market is being driven mainly by the increasing requirements to treat parasitic diseases in animals. Since parasitic attacks are known to support serious economic losses, parasiticides are needed to maintain the health of animals. Factors such as continuous growth in healthcare spending for animal health, rapidly increasing demand for animal-based foods and rise in livestock volumes, continuous increase in pet adoption levels, and the need to defense zoonotic diseases are turning growth in the global animal parasiticides market. Animal meat is a highly nutrient food and so are eggs and milk. With rising disposable incomes, consumers are demanding better quality food products, which is a key growth-promoting factor for the animal parasiticides market. Moreover, the animal welfare activities of governments focused on improving livestock health are also accelerating animal parasiticides market growth. With the number of companion animals on the rise, owners are taking preventive measures to defend the health of pets, thus stimulating growth in the animal parasiticides market.

The market is also being recommended by the steady growth in the numbers of veterinary practitioners, specifically in emerged regions. With the awareness regarding zoonotic diseases rising, governments are stressing efforts to defense transmission of animal diseases to humans, thus boosting demand for animal parasiticides. For instance, ESCAPE, a European body has built up guidelines to prevent, control, and treat companion animal parasites, since dogs and cats are often infested with vector-borne parasites such as ectoparasites and endoparasites. The objective of the European body is to overcome the risk of zoonotic transmission of parasitic diseases by protecting the health of pets. Growth in research activities for emerging innovative parasiticides would also turn the animal parasiticides market growth in the coming years. In addition, for example, Zoetis had remained focused on growing the company`s research for widenings its parasiticide and vaccine product ranges which help to cater the product in the animal parasiticides market.

Restraints:

The application of parasiticide in some animals (specifically the food producers) in some regions is restraining the animal parasiticides market. The growing number of species of parasites are also contributing to the restraints that are preventing the animal parasiticides market from growing. Moreover, the application of parasiticides in livestock animals is subject to various federal regulations in many economies. The extra-label use of these topical parasiticides could leave residues that may, on utilization by human beings, have side effects. As a result, the application of these parasiticides, especially endoparasiticides, needs to be regulated; safe residue concentrations and withdrawal periods for antiparasitics utilized in food-producing animals must be standardized, and slaughtered animals require to be monitored for possible unsafe residues. In the US, animal parasiticides given to food-producing animals have precise FDA-regulated withdrawal times (the time taken post drug administration for drug residues to reach limits set by the FDA) to prevent the presence of harmful drug residues. Similarly, according to the National Organic Program, animal parasiticides are restricted for all organic slaughter stock. In the UK, the Veterinary Medicines Directorate's non-statutory program, in cooperation with the National Surveillance Scheme, carries out residue analysis on imported and processed animal foods to ensure that authorized medicines, including parasiticides, are not present above the permitted level (known as the maximum residue limit) in food. In Canada, the Canadian Food Inspection Agency sets guidelines about withdrawal times for animal drugs, including animal parasiticides.

Opportunities:

Introducing the Door to More Digital Health Solutions

Last year, the start of the COVID-19 pandemic and showing lockdown restrictions led to many veterinarians and pet owners considering telemedicine solutions, owing to the prevention of some in-person appointments. And it's thought this will create the door to more widespread uptake of digital technology in animal care will help the growth of the animal parasiticide market. Already, many pet owners are buying wearable devices for their animals or using apps to monitor daily behavior and determine their four-legged friend on a deeper level. As per the research study, 56 percent of pet owners already own tech just for their pets. Such detailed information could demonstrate invaluable to support veterinary care and the application of artificial intelligence (AI) in practice, which depend on data sets so algorithms can 'learn' regarding a particular disease. Additionally, futuristic technologies are also capturing momentum. For instance, 3D printing is being utilized to build implants, prosthetic limbs, and even tissue replacements for pets. Veterinarians can also utilize 2D images such as scans to produce practice models in preparation for surgery. Vigorous animals are critical for a healthy planet, whether that's in the form of caring for pets, looking after livestock, or defending our wildlife. Continuous research and progress in 2021 and beyond will improve the understanding that can be better care-takers and is expected to grow of the animal parasiticides market in the upcoming years.

Market Segmentation

Segmentation Analysis of Animal Parasiticides Market:

Based on Type, the ectoparasiticides segment is expected to have a maximum animal parasiticides market share of the market, in terms of value during the forecast period. The segment is projected to expand owing to growth in infestation of fleas, ticks, and other ectoparasites to companion animals and livestock, which raises the chances of bacterial, viral, and parasitic disease transmission to humans. Hence, the application of ectoparasiticides is inevitable and important for pets and cattle. These factors are anticipated to turn the segment during the forecast period.

Based on the Animal Type, the companion animal segment is anticipated to record the maximum animal parasiticides market share over the forecast period. The growth of specialized R&D production units by key players in key economies globally and the rising adoption rate of pets as a companion, beast of burden, etc., have led to the major share held by the companion animals' segment of the global animal parasiticides market. Growth in gastrointestinal parasitism and zoonotic diseases among pets is probably to turn the animal parasiticides market over the forecast period.

Based on the End-Users, Veterinary Clinics & Hospitals segment is anticipated to dominate the animal parasiticides market over the forecast period. Largely incorporation of animal parasiticides in hospital settings, the rising incidence of parasitic diseases, and increasing consciousness regarding animal health in developing countries led to the growth of the animal parasiticides market.

Regional Analysis of Animal Parasiticides Market:

The Asia Pacific is estimated to be a highly attractive market for animal parasiticides and is probably to exhibit a significant attractiveness index. The market in the Asia Pacific is expected to grow at a high CAGR over the forecast period owing to the rising trading policy of meat in developing countries such as India and China. Growth in adoption of companion animals, rising in several production units of food-producing animals such as swine and poultry, and high utilization of meat in countries such as Australia & New Zealand, Japan, Malaysia, Singapore, and Taiwan are probably to accelerate the animal parasiticides market in the Asia Pacific during the forecast period.

North America is due to its well-established base of the animal health industry, the high adoption of companion animals, and the growing expenditure on animal health which leads to the growth of the animal parasiticides market during the forecast period.

The increasing trend of animal adoption and rising animal healthcare expenditure are the factors responsible for the expansion of the European market for animal parasiticides during the forecast period.

The animal parasiticides market in Latin America is expected to grow at an average growth rate during the forecast period owing to the rising production of pigs in Argentina and investment of government funding for research and development of parasiticides in Brazil. Moreover, the rising population of livestock animals, increasing utilization of animal-derived food products, and rising adoption of pets are helping to growth of the animal parasiticides market.

Players Covered in Animal Parasiticides market are 

•  Bayer AG (Germany)
•  Zoetis Inc. (US)
•  Virbac SA (France)
•  Elanco Animal Health (US)
•  Elanco Animal Health Incorporated (US)
•  Virbac (France)
•  Merck & Co. Inc. (the US)
•  Boehringer Ingelheim GmbH (Germany)
•  Bimeda Animal Health (US)
•  Merck Animal Health (US)
•  Ceva Santé Animale (France)
•  Vetoquinol S.A. (France)
•  PetIQ  Inc. (the US)
•  Norbrook (Ireland) and other major players.

Key Industry Developments In The Animal Parasiticides Market

• In June 2020, The European Commission has sanctioned, under the EU Merger Regulation, the proposed accession of Bayer AGs animal health division by Elanco Animal Health Inc. The decision is conditional on the privation of otitis products and different kinds of parasiticides in the European Economic Area (EEA), the UK, and globally.
• In August 2021, Zoetis Inc. (US) received Jurox (Australia) to build its product portfolio and production capacity with potential for global expansion.
• In June 2021, Boehringer Ingelheim collaborated with Lifebit (UK) to ascertain the global infectious disease epidemic using AI and natural language processing technology.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Animal Type
 3.3 By End User
 3.4 By Distribution Channels

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Animal Parasiticides Market by Type
 5.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 5.2 Animal Parasiticides Market Overview
 5.3 Ectoparasiticides
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Ectoparasiticides: Grographic Segmentation
 5.4 Endoparasiticides
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Endoparasiticides: Grographic Segmentation
 5.5 Endectocides
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Endectocides: Grographic Segmentation

Chapter 6: Animal Parasiticides Market by Animal Type
 6.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 6.2 Animal Parasiticides Market Overview
 6.3 Companion Animals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Companion Animals: Grographic Segmentation
 6.4 Livestock Animals
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Livestock Animals: Grographic Segmentation

Chapter 7: Animal Parasiticides Market by End User
 7.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 7.2 Animal Parasiticides Market Overview
 7.3 Animal Farms
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Animal Farms: Grographic Segmentation
 7.4 Home Care Settings
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Home Care Settings: Grographic Segmentation
 7.5 Veterinary Clinics & Hospitals
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Veterinary Clinics & Hospitals: Grographic Segmentation

Chapter 8: Animal Parasiticides Market by Distribution Channels
 8.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 8.2 Animal Parasiticides Market Overview
 8.3 Veterinary Hospitals & Clinics
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Veterinary Hospitals & Clinics: Grographic Segmentation
 8.4 Pharmacies
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Pharmacies: Grographic Segmentation
 8.5 Drug Stores
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Drug Stores: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Animal Parasiticides Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Animal Parasiticides Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Animal Parasiticides Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 BAYER AG
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 ZOETIS INC.
 9.4 VIRBAC SA
 9.5 ELANCO ANIMAL HEALTH
 9.6 ELANCO ANIMAL HEALTH INCORPORATED
 9.7 VIRBAC
 9.8 MERCK & CO. INC.
 9.9 BOEHRINGER INGELHEIM GMBH
 9.10 BIMEDA ANIMAL HEALTH
 9.11 MERCK ANIMAL HEALTH
 9.12 CEVA SANTÉ ANIMALE
 9.13 VETOQUINOL S.A.
 9.14 PETIQ INC.
 9.15 NORBROOK
 9.16 OTHER MAJOR PLAYERS

Chapter 10: Global Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Ectoparasiticides
  10.2.2 Endoparasiticides
  10.2.3 Endectocides
 10.3 Historic and Forecasted Market Size By Animal Type
  10.3.1 Companion Animals
  10.3.2 Livestock Animals
 10.4 Historic and Forecasted Market Size By End User
  10.4.1 Animal Farms
  10.4.2 Home Care Settings
  10.4.3 Veterinary Clinics & Hospitals
 10.5 Historic and Forecasted Market Size By Distribution Channels
  10.5.1 Veterinary Hospitals & Clinics
  10.5.2 Pharmacies
  10.5.3 Drug Stores

Chapter 11: North America Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Ectoparasiticides
  11.4.2 Endoparasiticides
  11.4.3 Endectocides
 11.5 Historic and Forecasted Market Size By Animal Type
  11.5.1 Companion Animals
  11.5.2 Livestock Animals
 11.6 Historic and Forecasted Market Size By End User
  11.6.1 Animal Farms
  11.6.2 Home Care Settings
  11.6.3 Veterinary Clinics & Hospitals
 11.7 Historic and Forecasted Market Size By Distribution Channels
  11.7.1 Veterinary Hospitals & Clinics
  11.7.2 Pharmacies
  11.7.3 Drug Stores
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Ectoparasiticides
  12.4.2 Endoparasiticides
  12.4.3 Endectocides
 12.5 Historic and Forecasted Market Size By Animal Type
  12.5.1 Companion Animals
  12.5.2 Livestock Animals
 12.6 Historic and Forecasted Market Size By End User
  12.6.1 Animal Farms
  12.6.2 Home Care Settings
  12.6.3 Veterinary Clinics & Hospitals
 12.7 Historic and Forecasted Market Size By Distribution Channels
  12.7.1 Veterinary Hospitals & Clinics
  12.7.2 Pharmacies
  12.7.3 Drug Stores
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Ectoparasiticides
  13.4.2 Endoparasiticides
  13.4.3 Endectocides
 13.5 Historic and Forecasted Market Size By Animal Type
  13.5.1 Companion Animals
  13.5.2 Livestock Animals
 13.6 Historic and Forecasted Market Size By End User
  13.6.1 Animal Farms
  13.6.2 Home Care Settings
  13.6.3 Veterinary Clinics & Hospitals
 13.7 Historic and Forecasted Market Size By Distribution Channels
  13.7.1 Veterinary Hospitals & Clinics
  13.7.2 Pharmacies
  13.7.3 Drug Stores
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Ectoparasiticides
  14.4.2 Endoparasiticides
  14.4.3 Endectocides
 14.5 Historic and Forecasted Market Size By Animal Type
  14.5.1 Companion Animals
  14.5.2 Livestock Animals
 14.6 Historic and Forecasted Market Size By End User
  14.6.1 Animal Farms
  14.6.2 Home Care Settings
  14.6.3 Veterinary Clinics & Hospitals
 14.7 Historic and Forecasted Market Size By Distribution Channels
  14.7.1 Veterinary Hospitals & Clinics
  14.7.2 Pharmacies
  14.7.3 Drug Stores
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Ectoparasiticides
  15.4.2 Endoparasiticides
  15.4.3 Endectocides
 15.5 Historic and Forecasted Market Size By Animal Type
  15.5.1 Companion Animals
  15.5.2 Livestock Animals
 15.6 Historic and Forecasted Market Size By End User
  15.6.1 Animal Farms
  15.6.2 Home Care Settings
  15.6.3 Veterinary Clinics & Hospitals
 15.7 Historic and Forecasted Market Size By Distribution Channels
  15.7.1 Veterinary Hospitals & Clinics
  15.7.2 Pharmacies
  15.7.3 Drug Stores
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ANIMAL PARASITICIDES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ANIMAL PARASITICIDES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ANIMAL PARASITICIDES MARKET COMPETITIVE RIVALRY
TABLE 005. ANIMAL PARASITICIDES MARKET THREAT OF NEW ENTRANTS
TABLE 006. ANIMAL PARASITICIDES MARKET THREAT OF SUBSTITUTES
TABLE 007. ANIMAL PARASITICIDES MARKET BY TYPE
TABLE 008. ECTOPARASITICIDES MARKET OVERVIEW (2016-2028)
TABLE 009. ENDOPARASITICIDES MARKET OVERVIEW (2016-2028)
TABLE 010. ENDECTOCIDES MARKET OVERVIEW (2016-2028)
TABLE 011. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE
TABLE 012. COMPANION ANIMALS MARKET OVERVIEW (2016-2028)
TABLE 013. LIVESTOCK ANIMALS MARKET OVERVIEW (2016-2028)
TABLE 014. ANIMAL PARASITICIDES MARKET BY END USER
TABLE 015. ANIMAL FARMS MARKET OVERVIEW (2016-2028)
TABLE 016. HOME CARE SETTINGS MARKET OVERVIEW (2016-2028)
TABLE 017. VETERINARY CLINICS & HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 018. ANIMAL PARASITICIDES MARKET BY DISTRIBUTION CHANNELS
TABLE 019. VETERINARY HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
TABLE 020. PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 021. DRUG STORES MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 024. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 025. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 026. N ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 029. EUROPE ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 030. EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 031. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 032. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 033. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 034. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 035. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 036. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 041. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 043. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 044. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 045. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 046. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 047. BAYER AG: SNAPSHOT
TABLE 048. BAYER AG: BUSINESS PERFORMANCE
TABLE 049. BAYER AG: PRODUCT PORTFOLIO
TABLE 050. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. ZOETIS INC.: SNAPSHOT
TABLE 051. ZOETIS INC.: BUSINESS PERFORMANCE
TABLE 052. ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 053. ZOETIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. VIRBAC SA: SNAPSHOT
TABLE 054. VIRBAC SA: BUSINESS PERFORMANCE
TABLE 055. VIRBAC SA: PRODUCT PORTFOLIO
TABLE 056. VIRBAC SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ELANCO ANIMAL HEALTH: SNAPSHOT
TABLE 057. ELANCO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 058. ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 059. ELANCO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. ELANCO ANIMAL HEALTH INCORPORATED: SNAPSHOT
TABLE 060. ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS PERFORMANCE
TABLE 061. ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT PORTFOLIO
TABLE 062. ELANCO ANIMAL HEALTH INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. VIRBAC: SNAPSHOT
TABLE 063. VIRBAC: BUSINESS PERFORMANCE
TABLE 064. VIRBAC: PRODUCT PORTFOLIO
TABLE 065. VIRBAC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MERCK & CO. INC.: SNAPSHOT
TABLE 066. MERCK & CO. INC.: BUSINESS PERFORMANCE
TABLE 067. MERCK & CO. INC.: PRODUCT PORTFOLIO
TABLE 068. MERCK & CO. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. BOEHRINGER INGELHEIM GMBH: SNAPSHOT
TABLE 069. BOEHRINGER INGELHEIM GMBH: BUSINESS PERFORMANCE
TABLE 070. BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
TABLE 071. BOEHRINGER INGELHEIM GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. BIMEDA ANIMAL HEALTH: SNAPSHOT
TABLE 072. BIMEDA ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 073. BIMEDA ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 074. BIMEDA ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. MERCK ANIMAL HEALTH: SNAPSHOT
TABLE 075. MERCK ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 076. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 077. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. CEVA SANTÉ ANIMALE: SNAPSHOT
TABLE 078. CEVA SANTÉ ANIMALE: BUSINESS PERFORMANCE
TABLE 079. CEVA SANTÉ ANIMALE: PRODUCT PORTFOLIO
TABLE 080. CEVA SANTÉ ANIMALE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. VETOQUINOL S.A.: SNAPSHOT
TABLE 081. VETOQUINOL S.A.: BUSINESS PERFORMANCE
TABLE 082. VETOQUINOL S.A.: PRODUCT PORTFOLIO
TABLE 083. VETOQUINOL S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. PETIQ INC.: SNAPSHOT
TABLE 084. PETIQ INC.: BUSINESS PERFORMANCE
TABLE 085. PETIQ INC.: PRODUCT PORTFOLIO
TABLE 086. PETIQ INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. NORBROOK: SNAPSHOT
TABLE 087. NORBROOK: BUSINESS PERFORMANCE
TABLE 088. NORBROOK: PRODUCT PORTFOLIO
TABLE 089. NORBROOK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 090. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 091. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 092. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ANIMAL PARASITICIDES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ANIMAL PARASITICIDES MARKET OVERVIEW BY TYPE
FIGURE 012. ECTOPARASITICIDES MARKET OVERVIEW (2016-2028)
FIGURE 013. ENDOPARASITICIDES MARKET OVERVIEW (2016-2028)
FIGURE 014. ENDECTOCIDES MARKET OVERVIEW (2016-2028)
FIGURE 015. ANIMAL PARASITICIDES MARKET OVERVIEW BY ANIMAL TYPE
FIGURE 016. COMPANION ANIMALS MARKET OVERVIEW (2016-2028)
FIGURE 017. LIVESTOCK ANIMALS MARKET OVERVIEW (2016-2028)
FIGURE 018. ANIMAL PARASITICIDES MARKET OVERVIEW BY END USER
FIGURE 019. ANIMAL FARMS MARKET OVERVIEW (2016-2028)
FIGURE 020. HOME CARE SETTINGS MARKET OVERVIEW (2016-2028)
FIGURE 021. VETERINARY CLINICS & HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 022. ANIMAL PARASITICIDES MARKET OVERVIEW BY DISTRIBUTION CHANNELS
FIGURE 023. VETERINARY HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 024. PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 025. DRUG STORES MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)